BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16962332)

  • 1. Influence of terminal branching on the transdermal permeation-enhancing activity in fatty alcohols and acids.
    Klimentová J; Kosák P; Vávrová K; Holas T; Hrabálek A
    Bioorg Med Chem; 2006 Dec; 14(23):7681-7. PubMed ID: 16962332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transkarbams with terminal branching as transdermal permeation enhancers.
    Klimentová J; Kosák P; Vávrová K; Holas T; Novotný J; Hrabálek A
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1712-5. PubMed ID: 18242986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural requirements for unsaturated fatty acids and fatty alcohols to induce optimal biological responses: an approach using model membranes.
    Castaing M; Camplo M; Kraus JL
    Res Commun Chem Pathol Pharmacol; 1993 Aug; 81(2):131-50. PubMed ID: 8210693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and transdermal permeation-enhancing activity of carbonate and carbamate analogs of Transkarbam 12.
    Holas T; Vávrová K; Síma M; Klimentová J; Hrabálek A
    Bioorg Med Chem; 2006 Dec; 14(23):7671-80. PubMed ID: 16942882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic studies of branched-chain alkanols as skin permeation enhancers.
    Chantasart D; Li SK; He N; Warner KS; Prakongpan S; Higuchi WI
    J Pharm Sci; 2004 Mar; 93(3):762-79. PubMed ID: 14762914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin permeation of physostigmine from fatty acids-based formulations: evaluating the choice of solvent.
    Wang MY; Yang YY; Heng PW
    Int J Pharm; 2005 Feb; 290(1-2):25-36. PubMed ID: 15664127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin.
    Andega S; Kanikkannan N; Singh M
    J Control Release; 2001 Nov; 77(1-2):17-25. PubMed ID: 11689256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-chain ceramides decrease skin barrier properties.
    Novotný J; Janůsová B; Novotný M; Hrabálek A; Vávrová K
    Skin Pharmacol Physiol; 2009; 22(1):22-30. PubMed ID: 19088499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and transdermal permeation-enhancing activity of ketone, amide, and alkane analogs of Transkarbam 12.
    Holas T; Vávrová K; Klimentová J; Hrabálek A
    Bioorg Med Chem; 2006 May; 14(9):2896-903. PubMed ID: 16376549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of sucrose fatty acid esters in transdermal therapeutic systems.
    Csóka G; Marton S; Zelko R; Otomo N; Antal I
    Eur J Pharm Biopharm; 2007 Feb; 65(2):233-7. PubMed ID: 16963242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of permeation enhancers and organic acids on the skin permeation of indapamide.
    Ren C; Fang L; Li T; Wang M; Zhao L; He Z
    Int J Pharm; 2008 Feb; 350(1-2):43-7. PubMed ID: 17888599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement effects of (R) and (S) enantiomers and the racemate of a model enhancer on permeation of theophylline through human skin.
    Vávrová K; Hrabálek A; Dolezal P
    Arch Dermatol Res; 2002 Nov; 294(8):383-5. PubMed ID: 12420109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fatty acids on the permeation of melatonin across rat and pig skin in-vitro and on the transepidermal water loss in rats in-vivo.
    Kandimalla K; Kanikkannan N; Andega S; Singh M
    J Pharm Pharmacol; 1999 Jul; 51(7):783-90. PubMed ID: 10467952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing effects of medium chain aliphatic alcohols and esters on the permeation of 6-carboxyfluorescein and indomethacin through rat skin.
    Seki T; Morimoto K
    Drug Deliv; 2003; 10(4):289-93. PubMed ID: 14612346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esters of 6-aminohexanoic acid as skin permeation enhancers: The effect of branching in the alkanol moiety.
    Hrabálek A; Vávrová K; Dolezal P; Machácek M
    J Pharm Sci; 2005 Jul; 94(7):1494-9. PubMed ID: 15942976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virucidal activities of medium- and long-chain fatty alcohols and lipids against respiratory syncytial virus and parainfluenza virus type 2: comparison at different pH levels.
    Hilmarsson H; Traustason BS; Kristmundsdóttir T; Thormar H
    Arch Virol; 2007; 152(12):2225-36. PubMed ID: 17891329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of different penetration enhancers on Lappaconitine transcutaneous permeation].
    Han M; Zhong YW; Li XP; Wu Z; Liang WQ; Gao JQ
    Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(11):1252-5. PubMed ID: 18831198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal delivery of penetrants with differing lipophilicities using O-acylmenthol derivatives as penetration enhancers.
    Zhao L; Fang L; Xu Y; Liu S; He Z; Zhao Y
    Eur J Pharm Biopharm; 2008 May; 69(1):199-213. PubMed ID: 18065216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a quantitative structure-permeability relationship (QSPR) for the transdermal delivery of NSAIDs.
    Liou YB; Ho HO; Yang CJ; Lin YK; Sheu MT
    J Control Release; 2009 Sep; 138(3):260-7. PubMed ID: 19467276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.